Palisade Bio Inc.

NASDAQ: PALI · Real-Time Price · USD
0.81
-0.00 (-0.61%)
At close: Aug 15, 2025, 3:58 PM
0.80
-1.45%
After-hours: Aug 15, 2025, 05:33 PM EDT

Palisade Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
4K 4K 4K -250K -250K -250K n/a 250K 250K 250K n/a n/a n/a n/a n/a 2.5K 5K 7.5K
Cost of Revenue
4K 5K 5K 57K 57K 83K 108K 80K 125K 147K 167K 185K 181K 132K 95.03K 51.02K 9.03K 9.03K
Gross Profit
n/a -1K -1K -307K -307K -333K -108K 170K 171K 149K -121K -139K -181K -132K -95.03K -48.52K -4.03K -1.52K
Operating Income
-12.13M -13.5M -14.86M -14.63M -14.82M -14.21M -13.07M -13.76M -14.4M -14.36M -15.72M -15.9M -14.5M -43.79M -41.85M -41.07M -39.87M -8.86M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3.92K 9.51K 9.51K 9.51K
Pretax Income
-11.85M -13.14M -14.44M -14.06M -14.17M -13.49M -12.3M -13.05M -13.44M -12.39M -14.26M -9.47M 2.61M -26.79M -24.87M -30.19M -40.12M -10.32M
Net Income
-11.85M -13.14M -14.44M -14.06M -14.17M -13.49M -12.3M -13.05M -13.44M -12.39M -14.26M -9.47M 2.61M -26.79M -26.62M -31.93M -41.86M -11.97M
Selling & General & Admin
5.28M 5.7M 5.79M 6.05M 6.27M 6.12M 6.2M 6.15M 6.55M 7.37M 8.76M 10.49M 10.8M 10.97M 9.31M 8.54M 7.55M 6.32M
Research & Development
6.85M 7.8M 9.06M 8.71M 8.32M 7.87M 6.89M 7.5M 7.69M 6.83M 6.55M 5M 3.7M 2.7M 2.43M 2.42M 2.2M 2.54M
Other Expenses
n/a n/a n/a 187K 549K 549K 549K 362K 410K 418K 419K 430K 58K 30.17M 30.17M 30.16M 30.12M 2K
Operating Expenses
12.13M 13.5M 14.86M 14.77M 14.95M 14.35M 13.46M 14.01M 14.65M 14.61M 15.72M 15.9M 14.5M 43.79M 41.85M 41.07M 39.87M 8.86M
Interest Expense
8K 12K 12K 13K 15K 16K 204K 203K 199K 201K 13K 15K 37K 687K 2.4M 3.43M 3.43M 2.79M
Selling & Marketing Expenses
n/a n/a -1K -1K -1K -1K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
9.29M 13.5M 14.86M 14.77M 14.95M 14.35M 13.46M 14.01M 14.65M 14.61M 15.72M 15.9M 14.5M 43.79M 41.85M 41.07M 39.87M 8.86M
Income Tax Expense
n/a n/a n/a n/a -1K -1K -1K -1K n/a n/a n/a n/a 26K 26K 1.74M 1.74M 1.74M 1.72M
Shares Outstanding (Basic)
4.8M 4.8M 5.82M 5.82M 5.82M 768.14K 5.82M 489.62K 6.4M 4.32M 1.8M 64.95K 405.9K 324.45K 270.66K 16.13K 152.43K 832.35K
Shares Outstanding (Diluted)
4.8M 4.8M 8.54M 5.82M 5.82M 12.63M 9.27M 489.62K 427.86K 287.7K 1.8M 64.95K 405.9K 324.48K 270.66K 242.13K 176.63K 237.39K
EPS (Basic)
-3.93 -6.67 -10.8 -10.74 -15.8 -20.41 -23.95 -24.93 -79.05 -157.67 -343.94 -338.49 38.01 -83.71 105.85 96.79 -220.42 -514.65
EPS (Diluted)
-3.75 -6.49 -10.62 -10.55 -15.61 -20.22 -23.76 -24.93 -79.05 -73.87 -79.68 -74.23 20.67 -156.32 -159.36 -181.2 -222.36 -50.42
EBITDA
-11.89M -13.13M -14.42M -14.05M -14.16M -13.47M -12.26M -13M -13.4M -12.31M -14.15M -9.31M 2.79M -26.01M -24.17M -29.34M -39.27M -10.02M
EBIT
-9.05M -13.13M -14.43M -14.05M -14.16M -13.47M -12.29M -13.04M -13.43M -12.38M -14.25M -9.45M 2.65M -26.1M -24.18M -29.31M -39.24M -9.99M
Depreciation & Amortization
-1K n/a n/a 46.81K 46.81K 72.81K 97.81K 80K 125K 147K 167K 185K 181K 133K 88K 45K 4K 3.5K